Dr Elizabeth Ilett
- Position: Lecturer
- Areas of expertise: cancer immunology; oncolytic viruses
- Email: E.Ilett@leeds.ac.uk
- Phone: +44(0)113 343 9675
- Location: 5.08 Wellcome Trust Brenner Building
Having graduated with a BA in Biochemistry from the University of Oxford, I later took an MSc in Immunology and Allergy at the University of Nottingham. After working for a short time as a research technician in Professor Maria Placzek’s Developmental Genetics team at the University of Sheffield, I joined Professor Alan Melcher’s Targeted and Biological Therapies lab in Leeds as a PhD student and continued to work in this group as a postdoc for several years. I now lead the Oncolytic Viruses and Immunotherapy Research Group.
My research is focused on oncolytic virotherapy for cancer, particularly with respect to the immunological potential of oncolytic viruses in generating anti-tumour immunity. I use human in vitro and murine in vivo models, mainly of melanoma, prostate and pancreatic cancer. I also study the effect of anti-viral immune responses on the systemic delivery of oncolytic viruses to tumours.
- PhD Exosomes for Cancer Immunotherapy
- MSc Immunology and Allergy
- BA (Hons) Biochemistry
- British Society for Immunology
Research groups and institutes
- Leeds Institute of Medical Research at St James's
<li><a href="//phd.leeds.ac.uk/project/577-mrc-dimen-doctoral-training-partnership:-the-impact-of-virus-specific-neutralizing-antibodies-on-oncolytic-virus-mediated-anti-tumour-immune-responses">MRC DiMeN Doctoral Training Partnership: The impact of virus-specific neutralizing antibodies on oncolytic virus-mediated anti-tumour immune responses</a></li>
<li><a href="//phd.leeds.ac.uk/project/382-using-biological-agents-to-enhance-t-cell-responses-to-tumours-">Using biological agents to enhance T cell responses to tumours </a></li>